Skip to main content

Table 1 Effects of pharmacist intervention on physician prescribing, frequency of seclusion use, and medicine costs

From: Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study

 

Pre-intervention in 2011 (n = 52)

Post-intervention in 2012 (n = 52)

p-value

Antipsychotic

   

 dose (mg)

982.6 (200.0–2395.1)

857.6 (75.0–2418.6)

p < 0.001

 No. of medicine(s)

2.0 (1.0–6.0)

2.0 (1.0–5.0)

p = 0.025

Concurrent agent n (%)

   

 anti-Parkinson

25 (48.1)

24 (46.2)

p = 0.500

 benzodiazepine

42 (80.8)

38 (73.1)

p = 0.243

 mood stabilizer

28 (53.8)

30 (57.5)

p = 0.423

Seclusion room use n (%)

23 (44.2)

15 (28.8)

p = 0.077

Cost (USD)

   

 all medicine

10.33 (1.33–104.79)

8.76 (0.45–34.16)

p = 0.045

 antipsychotic

8.04 (0.25–32.47)

6.48 (0.25–33.66)

p = 0.016

 psychotropic

9.42 (0.25–64.12)

7.68 (0.25–34.05)

p = 0.004

  1. Continuous variables indicate the median, and range in parentheses